The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
4D MOLECULAR THERAPEUTICS IN | COM | 35104E100 | 30,390,000 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
ABCELLERA BIOLOGICS INC | COM | 00288U106 | 6,434,685 | 1,126,915 | SH | SOLE | 1,126,915 | 0 | 0 | ||
ALIBABA GROUP HLDG LTD | SPONSORED ADS | 01609W102 | 38,819,101 | 500,827 | SH | SOLE | 500,827 | 0 | 0 | ||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 22,659,690 | 118,383 | SH | SOLE | 118,383 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 35,475,000 | 2,500,000 | SH | SOLE | 2,500,000 | 0 | 0 | ||
APPLE INC | COM | 037833100 | 42,637,694 | 221,460 | SH | SOLE | 221,460 | 0 | 0 | ||
ASML HOLDING N V | N Y REGISTRY SHS | N07059210 | 149,688,499 | 197,760 | SH | SOLE | 197,760 | 0 | 0 | ||
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 43,389,000 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 33,125,782 | 359,126 | SH | SOLE | 359,126 | 0 | 0 | ||
BROOKFIELD ASSET MANAGMT LTD | CL A LMT VTG SHS | 113004105 | 25,194,905 | 627,207 | SH | SOLE | 627,207 | 0 | 0 | ||
BROOKFIELD CORP | CL A LTD VT SH | 11271J107 | 155,674,828 | 3,880,230 | SH | SOLE | 3,880,230 | 0 | 0 | ||
CABLE ONE INC | COM | 12685J105 | 65,901,926 | 118,403 | SH | SOLE | 118,403 | 0 | 0 | ||
CARGO THERAPEUTICS INC | COM | 14179K101 | 28,937,500 | 1,250,000 | SH | SOLE | 1,250,000 | 0 | 0 | ||
CORCEPT THERAPEUTICS INC | COM | 218352102 | 78,321,038 | 2,411,362 | SH | SOLE | 2,411,362 | 0 | 0 | ||
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 39,138,000 | 1,100,000 | SH | SOLE | 1,100,000 | 0 | 0 | ||
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 21,258,000 | 900,000 | SH | SOLE | 900,000 | 0 | 0 | ||
EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 66,424,431 | 6,071,703 | SH | SOLE | 6,071,703 | 0 | 0 | ||
GALECTO INC | COM | 36322Q107 | 1,798,410 | 2,497,791 | SH | SOLE | 2,497,791 | 0 | 0 | ||
INSMED INC | COM PAR $.01 | 457669307 | 41,505,031 | 1,339,304 | SH | SOLE | 1,339,304 | 0 | 0 | ||
INSPIRE MED SYS INC | COM | 457730109 | 13,329,547 | 65,524 | SH | SOLE | 65,524 | 0 | 0 | ||
IO BIOTECH INC | COM | 449778109 | 10,804,486 | 5,747,067 | SH | SOLE | 5,747,067 | 0 | 0 | ||
LANZATECH GLOBAL INC | COM | 51655R101 | 79,548,670 | 15,814,845 | SH | SOLE | 15,814,845 | 0 | 0 | ||
LAVA THERAPEUTICS NV | SHS | N51517105 | 2,967,547 | 1,878,194 | SH | SOLE | 1,878,194 | 0 | 0 | ||
LEXEO THERAPEUTICS INC | COM | 52886X107 | 17,551,065 | 1,307,829 | SH | SOLE | 1,307,829 | 0 | 0 | ||
MARQETA INC | CLASS A COM | 57142B104 | 3,082,075 | 441,558 | SH | SOLE | 441,558 | 0 | 0 | ||
MIRUM PHARMACEUTICALS INC | COM | 604749101 | 44,280,000 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
PHARVARIS N V | COM | N69605108 | 43,178,066 | 1,539,325 | SH | SOLE | 1,539,325 | 0 | 0 | ||
RALLYBIO CORP | COM | 75120L100 | 4,225,188 | 1,767,861 | SH | SOLE | 1,767,861 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 31,468,500 | 1,050,000 | SH | SOLE | 1,050,000 | 0 | 0 | ||
SALESFORCE.COM, INC. | COM | 79466L302 | 139,595,770 | 530,500 | SH | SOLE | 530,500 | 0 | 0 | ||
SPERO THERAPEUTICS INC | COM | 84833T103 | 123,386,872 | 468,902 | SH | SOLE | 468,902 | 0 | 0 | ||
SPRUCE BIOSCIENCES INC | COM | 85209E109 | 19,696,444 | 6,722,336 | SH | SOLE | 6,722,336 | 0 | 0 | ||
TAIWAN SEMICONDUCTOR MFG LTD | SPONSORED ADS | 874039100 | 73,921,120 | 710,780 | SH | SOLE | 710,780 | 0 | 0 | ||
TREACE MED CONCEPTS INC | COM | 89455T109 | 4,590,000 | 360,000 | SH | SOLE | 360,000 | 0 | 0 | ||
VAXCYTE INC | COM | 92243G108 | 53,066,000 | 845,000 | SH | SOLE | 845,000 | 0 | 0 | ||
VERVE THERAPEUTICS INC | COM | 92539P101 | 27,880,000 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 |